PMC:7443692 / 995-1429 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T6","span":{"begin":321,"end":331},"obj":"Species"},{"id":"T7","span":{"begin":385,"end":390},"obj":"Species"}],"attributes":[{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"},{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T8","span":{"begin":62,"end":217},"obj":"Sentence"},{"id":"T9","span":{"begin":219,"end":237},"obj":"Sentence"},{"id":"T10","span":{"begin":239,"end":249},"obj":"Sentence"},{"id":"T11","span":{"begin":250,"end":337},"obj":"Sentence"},{"id":"T12","span":{"begin":338,"end":418},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T3","span":{"begin":201,"end":216},"obj":"Disease"},{"id":"T4","span":{"begin":321,"end":331},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T276","span":{"begin":33,"end":37},"obj":"Protein"},{"id":"T277","span":{"begin":391,"end":395},"obj":"Protein"}],"attributes":[{"id":"A276","pred":"uniprot_id","subj":"T276","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A277","pred":"uniprot_id","subj":"T277","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T6","span":{"begin":207,"end":216},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T7","span":{"begin":253,"end":257},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T8","span":{"begin":312,"end":317},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T9","span":{"begin":345,"end":350},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T8","span":{"begin":132,"end":140},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T3","span":{"begin":47,"end":60},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T4","span":{"begin":201,"end":216},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T3","span":{"begin":47,"end":60},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T4","span":{"begin":201,"end":216},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T22","span":{"begin":33,"end":37},"obj":"G_3;PG_10;PR:000003622"},{"id":"T23","span":{"begin":104,"end":113},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T24","span":{"begin":132,"end":140},"obj":"GO:0042571"},{"id":"T25","span":{"begin":201,"end":206},"obj":"NCBITaxon:10239"},{"id":"T26","span":{"begin":321,"end":331},"obj":"SP_7"},{"id":"T27","span":{"begin":385,"end":390},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T28","span":{"begin":391,"end":395},"obj":"PG_10;PR:000003622"}],"text":"influence of natural variants on ACE2 receptor glycosylation. Taken together, these data can facilitate immunogen design to achieve antibody neutralization and inform therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dy"}